Enveric Biosciences, Inc. (ENVB)
1.47
-0.04
(-2.65%)
USD |
NASDAQ |
Oct 06, 16:00
1.45
-0.02
(-1.36%)
Pre-Market: 20:00
Enveric Biosciences EPS Diluted (Quarterly) : -0.7594 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.7594 |
| March 31, 2026 | -1.082 |
| December 31, 2025 | -3.806 |
| September 30, 2025 | -10.81 |
| June 30, 2025 | -11.65 |
| March 31, 2025 | -1.215 |
| December 31, 2024 | -57.80 |
| September 30, 2024 | -0.2395 |
| June 30, 2024 | -0.2477 |
| March 31, 2024 | -0.614 |
| December 31, 2023 | -1.463 |
| September 30, 2023 | -1.304 |
| June 30, 2023 | -3.036 |
| March 31, 2023 | -2.31 |
| December 31, 2022 | -4.235 |
| September 30, 2022 | -1.456 |
| June 30, 2022 | -2.648 |
| March 31, 2022 | -5.340 |
| December 31, 2021 | -64.62 |
| September 30, 2021 | -5.86 |
| June 30, 2021 | -2.129 |
| March 31, 2021 | -10.02 |
| September 30, 2020 | -3472.20 |
| June 30, 2020 | -5194.44 |
| March 31, 2020 | -6994.44 |
| Date | Value |
|---|---|
| December 31, 2019 | -209.04 |
| September 30, 2019 | -6.10 |
| June 30, 2019 | -134.45 |
| March 31, 2019 | -217.50 |
| December 31, 2018 | -2761.65 |
| September 30, 2018 | 802.80 |
| June 30, 2018 | -363.05 |
| March 31, 2018 | -570.70 |
| December 31, 2017 | -450.00 |
| September 30, 2017 | -1550.00 |
| June 30, 2017 | -1300.00 |
| March 31, 2017 | -78030.00 |
| December 31, 2016 | 468.30 |
| September 30, 2016 | -650.00 |
| June 30, 2016 | -81000.00 |
| March 31, 2016 | -500.00 |
| December 31, 2015 | -750.00 |
| September 30, 2015 | -100.00 |
| June 30, 2015 | 50.00 |
| March 31, 2015 | -14.97 |
| December 31, 2014 | -60.75 |
| September 30, 2014 | -18.49 |
| June 30, 2014 | -67.80 |
| March 31, 2014 | -46.67 |
| December 31, 2013 | 94.21 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| LENZ Therapeutics, Inc. | -1.017 |
| Impact BioMedical, Inc. | -0.0818 |
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.028M |
| Total Expenses (Quarterly) | 3.028M |
| Enterprise Value | -2.510M |
| Earnings Yield | -1.12K% |
| Normalized Earnings Yield | -1119.72 |